2003
DOI: 10.1016/j.mad.2003.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Growth hormone administration to long-living dwarf mice alters multiple components of the antioxidative defense system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
61
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 82 publications
(66 citation statements)
references
References 30 publications
5
61
0
Order By: Relevance
“…Previous studies have focused on antioxidative defense, oxidative damage, and pathways leading to and including glutathione metabolism. We believe that the reduced GH signaling in the Ames mouse contributes to the enhanced antioxidative capacity, lower damage to proteins and DNA, and an increase in functioning of the methionine and glutathione metabolic pathways (Brown-Borg and Rakoczy 2003;Uthus and Brown-Borg 2003). An integral player in each of these observations is the mitochondria, organelles that drive energy metabolism, and possibly cellular aging according to several hypotheses of aging.…”
Section: Discussionmentioning
confidence: 96%
“…Previous studies have focused on antioxidative defense, oxidative damage, and pathways leading to and including glutathione metabolism. We believe that the reduced GH signaling in the Ames mouse contributes to the enhanced antioxidative capacity, lower damage to proteins and DNA, and an increase in functioning of the methionine and glutathione metabolic pathways (Brown-Borg and Rakoczy 2003;Uthus and Brown-Borg 2003). An integral player in each of these observations is the mitochondria, organelles that drive energy metabolism, and possibly cellular aging according to several hypotheses of aging.…”
Section: Discussionmentioning
confidence: 96%
“…GH Administration-25 g of recombinant human GH (Reprokine) dissolved in water was injected subcutaneously twice daily (23). The site of injection was rotated daily to minimize discomfort, and weight measurements were taken in the morning prior to injection.…”
Section: Methodsmentioning
confidence: 99%
“…References; 1, Brown-Borg et al 2001;2, Brooks et al 2007;3, Hauck et al 2002 IIS insulin/IGF-1 signalling pathway mutant Irs1 −/− ; insulin receptor substrate-1 knockout GH growth hormone GHRKO growth hormone receptor/binding protein knockout M male and F female a Significant difference at young (3 months) but no difference at old age (24 months) b Significant difference at old age (24 month) but no difference at young age (3 months) c MDA+4-HNE; significant differences at middle-age (12 months) and old age (24 months) but no differences at young age (3 months) levels have previously been shown to be increased in brain, liver, and muscle tissue of Ames dwarf mice (Brown-Borg and Rakoczy 2003), as well as in dermal fibroblasts of Snell dwarf mice (Leiser and Miller 2010). Perhaps surprisingly, we observed no difference in protein (carbonyls) or lipid (4-HNE) oxidative damage in brain, skeletal muscle, or liver between Irs1 −/− and WT mice.…”
Section: Nsmentioning
confidence: 97%